A detailed history of Ted Buchan & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ted Buchan & CO holds 22,257 shares of BMY stock, worth $1.28 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
22,257
Holding current value
$1.28 Million
% of portfolio
0.55%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$39.66 - $51.75 $882,712 - $1.15 Million
22,257 New
22,257 $1.15 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ted Buchan & CO Portfolio

Follow Ted Buchan & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ted Buchan & CO, based on Form 13F filings with the SEC.

News

Stay updated on Ted Buchan & CO with notifications on news.